🔎 Trials Near Me

Home › Chronic Kidney Disease › Virginia

Chronic Kidney Disease clinical trials in Virginia

6 studies for Chronic Kidney Disease are looking for participants at sites in Virginia.

Cities in Virginia

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Carient Heart & Vascular - Manassas, Manassas
  • Carient Heart and Vascular LLC-Reston, Reston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07783802

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Arlington
  • Research Site, Manassas
  • Research Site, Newport News
  • and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06742723

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

  • Research Site, Arlington
  • Research Site, Richmond
  • Research Site, Woodbridge
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 24, 2026 · NCT07624305

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  • Research Site, Arlington
  • Research Site, Norfolk
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07753993

Kidney Function in People With Cystic Fibrosis in the Era of HEMT

  • University of Virginia Children's Hospital, Charlottesville
RecruitingObservational studyHealthy volunteers welcome
Ages 7 and older · All sexes · Updated May 4, 2026 · NCT06595420

Transformative Research in Diabetic Nephropathy

  • University of Virginia, Charlottesville
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Feb 27, 2026 · NCT02986984

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.